Glaukos (GKOS) Financials

$86.80 -0.81 (-0.92%)

Closing price 03:59 PM Eastern

Extended Trading

$86.87 +0.07 (+0.08%)

As of 04:43 PM Eastern

Annual Income Statements for Glaukos

This table shows Glaukos' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-37	4.52	-0.09	-13	15	-120	-50	-99	-135	-146
Consolidated Net Income / (Loss)	-38	4.52	-0.09	-13	15	-120	-50	-99	-135	-146
Net Income / (Loss) Continuing Operations	-38	4.52	-0.09	-13	15	-120	-50	-99	-135	-146
Total Pre-Tax Income	-38	4.57	0.00	-12	-50	-132	-49	-98	-134	-146
Total Operating Income	-10	4.24	-2.28	-13	-50	-124	-33	-82	-129	-122
Total Gross Profit	59	98	138	156	198	133	227	214	239	289
Total Revenue	72	114	159	181	237	225	294	283	315	383
Operating Revenue	72	114	159	181	237	225	294	283	315	383
Total Cost of Revenue	13	16	21	25	39	92	67	69	76	94
Operating Cost of Revenue	13	16	21	25	39	92	67	69	76	94
Total Operating Expenses	69	94	140	169	249	257	260	296	368	412
Selling, General & Admin Expense	44	65	96	-	177	171	179	193	224	261
Research & Development Expense	25	29	44	50	72	85	111	133	144	151
Other Special Charges / (Income)	-	-	-	-	0.00	-	-30	-30	0.00	0.00
Total Other Income / (Expense), net	-28	0.32	2.28	0.63	0.51	-8.76	-16	-16	-5.03	-23
Interest Expense	1.26	-	-0.91	1.62	2.91	11	18	18	14	34
Interest & Investment Income	-26	0.89	1.38	2.25	3.17	2.38	1.29	2.38	9.16	11
Income Tax Expense	0.03	0.04	0.09	0.58	-65	-12	0.33	0.77	0.93	0.77
Basic Earnings per Share	($2.13)	$0.14	$0.00	($0.37)	$0.41	($2.70)	($1.07)	($2.09)	($2.78)	($2.77)
Weighted Average Basic Shares Outstanding	17.47M	32.93M	34.38M	35.32M	37.36M	44.50M	46.42M	47.44M	48.43M	52.76M
Diluted Earnings per Share	($2.13)	$0.12	$0.00	($0.37)	$0.37	($2.70)	($1.07)	($2.09)	($2.78)	($2.77)
Weighted Average Diluted Shares Outstanding	17.47M	36.46M	34.38M	35.32M	41.15M	44.50M	46.42M	47.44M	48.43M	52.76M
Weighted Average Basic & Diluted Shares Outstanding	17.50M	32.30M	34.74M	35M	43.74M	45.79M	47.05M	47.88M	49.47M	56.57M

This table shows Glaukos' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-28	-31	-35	-33	-30	-37	-41	-51	-21	-34	-18
Consolidated Net Income / (Loss)	-28	-31	-35	-33	-30	-37	-41	-51	-21	-34	-18
Net Income / (Loss) Continuing Operations	-28	-31	-35	-33	-30	-37	-41	-51	-21	-34	-18
Total Pre-Tax Income	-27	-31	-34	-32	-30	-37	-40	-50	-21	-34	-18
Total Operating Income	-22	-34	-33	-29	-28	-39	-39	-30	-25	-29	-21
Total Gross Profit	54	54	56	60	60	63	65	73	74	77	82
Total Revenue	71	71	74	80	78	82	86	96	97	105	107
Operating Revenue	71	71	74	80	78	82	86	96	97	105	107
Total Cost of Revenue	17	17	18	20	19	19	20	23	23	29	24
Operating Cost of Revenue	17	17	18	20	19	19	20	23	23	29	24
Total Operating Expenses	76	88	89	89	88	102	104	103	99	106	103
Selling, General & Admin Expense	47	52	54	53	54	63	62	66	64	69	71
Research & Development Expense	29	36	35	36	33	39	42	37	35	37	32
Total Other Income / (Expense), net	-5.72	2.57	-1.23	-3.30	-2.40	1.90	-1.40	-20	3.43	-5.03	2.86
Interest Expense	3.48	8.18	3.41	3.40	3.40	3.99	3.45	21	1.66	7.86	1.16
Interest & Investment Income	-2.24	3.94	2.18	1.89	2.71	2.38	3.08	2.83	2.70	2.49	3.08
Other Income / (Expense), net	-	-	-	-1.80	-1.71	-	-1.03	-1.70	2.39	-	0.95
Income Tax Expense	0.25	0.30	0.40	0.44	0.04	0.06	0.38	0.33	0.18	-0.11	0.33
Basic Earnings per Share	($0.58)	($0.66)	($0.72)	($0.68)	($0.63)	($0.75)	($0.82)	($1.00)	($0.39)	($0.56)	($0.32)
Weighted Average Basic Shares Outstanding	47.61M	47.44M	47.88M	48.28M	48.68M	48.43M	49.58M	50.72M	55.04M	52.76M	56.64M
Diluted Earnings per Share	($0.58)	($0.66)	($0.72)	($0.68)	($0.63)	($0.75)	($0.82)	($1.00)	($0.39)	($0.56)	($0.32)
Weighted Average Diluted Shares Outstanding	47.61M	47.44M	47.88M	48.28M	48.68M	48.43M	49.58M	50.72M	55.04M	52.76M	56.64M
Weighted Average Basic & Diluted Shares Outstanding	47.70M	47.88M	48.21M	48.65M	48.80M	49.47M	50.37M	54.95M	55.14M	56.57M	57.14M

This table details how cash moves in and out of Glaukos' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	19	-15	18	14	33	34	3.96	16	-27	75
Net Cash From Operating Activities	-2.19	12	26	19	-0.37	-23	25	-33	-58	-61
Net Cash From Continuing Operating Activities	-2.19	12	26	19	-0.37	-23	25	-33	-58	-61
Net Income / (Loss) Continuing Operations	-38	4.52	-0.09	-13	15	-120	-50	-99	-135	-146
Consolidated Net Income / (Loss)	-38	4.52	-0.09	-13	15	-120	-50	-99	-135	-146
Depreciation Expense	4.27	4.72	5.48	6.26	6.31	4.47	4.75	6.66	8.74	11
Amortization Expense	0.07	0.21	0.02	-0.30	3.22	61	32	31	25	30
Non-Cash Adjustments To Reconcile Net Income	35	9.15	17	28	49	47	35	42	54	84
Changes in Operating Assets and Liabilities, net	-3.38	-6.30	4.03	-1.66	-75	-15	2.55	-14	-10	-40
Net Cash From Investing Activities	-86	-26	-12	-26	43	-205	-58	45	14	48
Net Cash From Continuing Investing Activities	-86	-26	-12	-26	43	-205	-58	45	14	48
Purchase of Property, Plant & Equipment	-0.88	-6.28	-6.31	-10	-4.72	-6.94	-48	-30	-20	-6.30
Purchase of Investments	-70	-75	-94	-94	-80	-301	-215	-59	-266	-190
Sale of Property, Plant & Equipment	-	-	-	-	0.00	0.00	0.00	0.15	0.00	0.04
Sale and/or Maturity of Investments	-	55	89	79	80	105	207	135	303	247
Other Investing Activities, net	-15	-	-0.66	-1.24	-1.61	-1.82	-2.08	-1.01	-3.17	-3.15
Net Cash From Financing Activities	107	-1.64	4.67	22	-9.65	263	39	6.25	15	92
Net Cash From Continuing Financing Activities	107	-1.64	4.67	22	-9.65	263	39	6.25	15	92
Repayment of Debt	-18	-9.70	-	0.00	-22	-9.61	0.00	0.00	0.00	-0.71
Issuance of Debt	8.60	-	-	0.00	0.00	288	-	0.00	0.00	53
Issuance of Common Equity	115	1.95	0.97	3.51	3.39	4.03	4.82	5.63	6.28	7.42
Other Financing Activities, net	2.16	6.11	3.70	18	9.46	-19	34	0.62	8.76	32
Effect of Exchange Rate Changes	-0.03	0.37	-0.43	0.05	-0.25	-0.09	-1.77	-1.47	1.34	-3.02
Cash Interest Paid	0.83	0.29	-	0.00	0.00	5.38	12	12	12	9.21
Cash Income Taxes Paid	0.03	0.51	0.01	0.40	0.17	0.48	0.27	0.52	1.56	1.36

This table details how cash moves in and out of Glaukos' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Net Change in Cash & Equivalents	1.42	14	-43	17	14	-15	-51	24	32	69	-55
Net Cash From Operating Activities	-27	-4.14	-31	-8.16	-8.17	-11	-34	-18	-9.59	0.51	-19
Net Cash From Continuing Operating Activities	-27	-4.14	-31	-8.16	-8.17	-11	-34	-18	-9.59	0.51	-19
Net Income / (Loss) Continuing Operations	-28	-31	-35	-33	-30	-37	-41	-51	-21	-34	-18
Consolidated Net Income / (Loss)	-28	-31	-35	-33	-30	-37	-41	-51	-21	-34	-18
Depreciation Expense	1.67	1.95	2.08	2.15	2.23	2.29	2.69	2.75	2.74	2.77	2.65
Amortization Expense	6.73	10	6.52	6.29	5.87	5.93	5.46	5.38	5.36	13	5.51
Non-Cash Adjustments To Reconcile Net Income	13	7.80	12	16	13	13	21	32	14	16	15
Changes in Operating Assets and Liabilities, net	-20	7.23	-16	0.25	1.00	4.95	-22	-8.23	-11	1.68	-23
Net Cash From Investing Activities	24	17	-14	26	15	-13	-29	35	31	12	-37
Net Cash From Continuing Investing Activities	24	17	-14	26	15	-13	-29	35	31	12	-37
Purchase of Property, Plant & Equipment	-6.04	-8.22	-6.91	-5.77	-3.36	-4.21	-0.97	-2.15	-1.45	-1.73	-1.94
Purchase of Investments	-10	-12	-96	-74	-23	-72	-49	-42	-32	-67	-75
Sale and/or Maturity of Investments	41	38	90	107	42	64	22	80	65	80	41
Other Investing Activities, net	0.00	-0.84	-0.53	-1.52	-0.10	-1.02	-1.05	-1.04	-1.15	0.08	-1.15
Net Cash From Financing Activities	4.21	0.53	1.15	-0.88	7.47	7.30	13	8.59	9.67	60	1.95
Net Cash From Continuing Financing Activities	4.21	0.53	1.15	-0.88	7.47	7.30	13	8.59	9.67	60	1.95
Issuance of Common Equity	3.85	-	2.16	-	4.12	-	2.69	-	4.73	-	2.96
Other Financing Activities, net	0.36	0.53	-1.01	-0.88	3.35	7.30	10	8.59	4.94	7.60	-1.01
Other Net Changes in Cash	-	-	-	-	-	-	-	-	-	-	-1.86
Cash Interest Paid	1.16	5.04	1.09	5.03	1.08	5.06	1.07	5.20	1.08	1.86	1.06
Cash Income Taxes Paid	0.13	0.15	0.26	0.53	0.44	0.34	0.35	0.45	0.36	0.20	0.28

This table presents Glaukos' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	117	134	166	207	818	1,006	1,050	1,002	940	975
Total Current Assets	104	120	149	177	263	469	486	444	395	450
Cash & Equivalents	22	6.49	25	30	62	97	101	120	93	170
Short-Term Investments	70	89	95	111	112	308	313	233	202	149
Accounts Receivable	7.55	14	17	19	38	36	33	36	40	61
Inventories, net	4.10	6.84	11	13	43	16	23	38	42	58
Prepaid Expenses	1.29	3.03	2.57	4.12	7.90	13	16	17	18	12
Plant, Property, & Equipment, net	2.15	7.59	12	19	22	24	69	94	103	98
Total Noncurrent Assets	10	6.76	4.58	11	533	512	495	464	442	427
Noncurrent Note & Lease Receivables	-	-	-	-	54	51	49	47	44	42
Goodwill	-	-	-	-	66	66	66	66	66	66
Intangible Assets	10	6.57	3.15	-	383	358	333	308	283	263
Other Noncurrent Operating Assets	0.15	0.19	1.20	2.26	21	27	37	36	43	51
Other Noncurrent Nonoperating Assets	-	-	-	8.78	9.33	9.57	9.42	7.08	5.86	4.73
Total Liabilities & Shareholders' Equity	117	134	166	207	818	1,006	1,050	1,002	940	975
Total Liabilities	21	17	28	33	145	338	463	472	479	208
Total Current Liabilities	20	17	27	30	58	50	63	72	74	75
Accounts Payable	3.63	2.97	6.24	6.29	5.78	4.37	7.33	14	13	13
Accrued Expenses	7.79	14	20	24	52	45	56	58	61	62
Total Noncurrent Liabilities	1.11	0.16	0.85	2.75	87	288	399	400	405	133
Long-Term Debt	0.77	-	-	-	0.00	189	280	281	283	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	9.63	11	7.32	7.26	7.14	6.93
Other Noncurrent Operating Liabilities	0.34	0.16	0.85	2.75	78	88	112	111	115	126
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	95	117	138	174	673	667	587	530	462	767
Total Preferred & Common Equity	95	117	138	174	673	667	587	530	462	767
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	95	117	138	174	673	667	587	530	462	767
Common Stock	292	309	331	378	862	977	952	998	1,060	1,510
Retained Earnings	-197	-192	-192	-205	-190	-310	-365	-464	-599	-745
Treasury Stock	-0.13	-0.13	-0.13	-0.13	-0.13	-0.13	-	-0.13	-0.13	-0.13
Accumulated Other Comprehensive Income / (Loss)	0.05	0.65	-0.59	0.74	1.33	1.00	0.02	-2.98	1.17	2.62

This table presents Glaukos' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025
Total Assets	1,008	973	957	949	933	920	927	966
Total Current Assets	449	416	401	400	389	384	397	445
Cash & Equivalents	104	76	95	109	42	68	100	114
Short-Term Investments	258	241	209	192	230	194	162	184
Accounts Receivable	35	38	39	39	47	51	56	72
Inventories, net	34	40	39	40	50	56	60	59
Prepaid Expenses	18	20	19	20	19	14	19	15
Plant, Property, & Equipment, net	87	98	103	103	102	100	99	97
Total Noncurrent Assets	463	458	453	446	443	436	431	425
Noncurrent Note & Lease Receivables	47	46	45	45	44	43	42	41
Goodwill	66	66	66	66	66	66	66	66
Intangible Assets	314	302	295	289	282	276	269	258
Other Noncurrent Operating Assets	26	38	40	40	45	46	48	55
Other Noncurrent Nonoperating Assets	9.08	7.08	5.86	5.86	5.86	4.73	4.73	4.73
Total Liabilities & Shareholders' Equity	1,008	973	957	949	933	920	927	966
Total Liabilities	460	464	468	471	483	255	258	202
Total Current Liabilities	61	62	64	67	72	70	72	69
Accounts Payable	11	12	8.56	10	13	12	11	16
Accrued Expenses	49	50	55	57	59	59	61	53
Total Noncurrent Liabilities	399	402	404	404	410	184	186	134
Noncurrent Deferred & Payable Income Tax Liabilities	7.30	7.26	7.26	7.25	7.14	7.14	7.14	6.92
Other Noncurrent Operating Liabilities	111	113	115	114	120	121	122	127
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	549	509	489	478	451	665	669	764
Total Preferred & Common Equity	549	509	489	478	451	665	669	764
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	549	509	489	478	451	665	669	764
Common Stock	985	1,009	1,021	1,039	1,089	1,354	1,378	1,525
Retained Earnings	-433	-499	-532	-562	-640	-690	-712	-764
Treasury Stock	-0.13	-0.13	-0.13	-0.13	-0.13	-0.13	-0.13	-0.13
Accumulated Other Comprehensive Income / (Loss)	-3.82	-1.33	-0.39	0.76	1.44	2.19	2.62	2.61

This table displays calculated financial ratios and metrics derived from Glaukos' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	57.28%	59.55%	39.21%	13.83%	30.73%	-5.07%	30.70%	-3.79%	11.26%	21.85%
EBITDA Growth	20.59%	221.32%	-62.58%	-318.35%	-476.01%	-42.68%	106.83%	-1,239.09%	-111.93%	14.30%
EBIT Growth	13.20%	132.17%	-162.05%	-470.01%	-284.83%	-146.93%	73.39%	-150.40%	-56.35%	4.92%
NOPAT Growth	21.83%	158.29%	4,895.23%	-104.34%	-286.80%	-145.67%	73.39%	-150.40%	-56.35%	4.92%
Net Income Growth	-172.61%	111.80%	-102.03%	-13,977.17%	219.10%	-880.26%	58.79%	-100.02%	-35.75%	-8.70%
EPS Growth	59.74%	105.63%	-100.00%	0.00%	200.00%	-829.73%	60.37%	-95.33%	-33.01%	0.36%
Operating Cash Flow Growth	69.21%	662.57%	111.97%	-27.70%	-101.96%	-6,129.81%	207.48%	-233.90%	-74.59%	-6.16%
Free Cash Flow Firm Growth	67.24%	52.24%	6,077.99%	-106.84%	-3,349.74%	92.12%	39.71%	-175.51%	-24.67%	-4.87%
Invested Capital Growth	1.65%	56.63%	-10.47%	28.19%	1,891.96%	-9.60%	0.18%	1.79%	-1.86%	0.01%
Revenue Q/Q Growth	0.00%	12.71%	5.62%	7.36%	5.23%	3.39%	0.00%	-0.71%	3.67%	6.42%
EBITDA Q/Q Growth	0.00%	32.37%	8.56%	12.12%	-216.34%	46.40%	-89.48%	-40.25%	-11.32%	14.33%
EBIT Q/Q Growth	0.00%	107.92%	2.73%	9.50%	-167.60%	12.90%	-24.54%	-23.88%	-3.95%	7.52%
NOPAT Q/Q Growth	0.00%	137.62%	12,884.16%	9.50%	-168.97%	12.90%	-24.54%	-23.88%	-3.95%	7.52%
Net Income Q/Q Growth	0.00%	115.54%	90.46%	5.63%	179.60%	-64.59%	-29.25%	-10.70%	-4.11%	2.14%
EPS Q/Q Growth	0.00%	-98.73%	100.00%	2.63%	169.81%	-75.32%	-30.49%	-10.58%	-3.35%	6.42%
Operating Cash Flow Q/Q Growth	-43.57%	76.73%	54.32%	32.86%	-101.76%	39.16%	-38.17%	1.53%	-12.74%	15.41%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	4,048.54%	-17.57%	-3,062.04%	92.43%	-129.86%	-22.92%	10.10%	11.95%
Invested Capital Q/Q Growth	0.00%	9.58%	-17.61%	-3.82%	1,630.34%	-1.68%	0.31%	0.55%	-2.23%	-3.23%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	81.89%	85.86%	86.78%	86.17%	83.72%	59.23%	77.34%	75.61%	75.99%	75.48%
EBITDA Margin	-9.90%	7.52%	2.02%	-3.88%	-17.09%	-25.69%	1.34%	-15.91%	-30.30%	-21.31%
Operating Margin	-14.36%	3.71%	-1.43%	-7.17%	-21.22%	-54.92%	-11.18%	-29.10%	-40.89%	-31.91%
EBIT Margin	-15.94%	3.21%	-1.43%	-7.17%	-21.11%	-54.92%	-11.18%	-29.10%	-40.89%	-31.91%
Profit (Net Income) Margin	-53.45%	3.95%	-0.06%	-7.14%	6.51%	-53.50%	-16.87%	-35.07%	-42.79%	-38.17%
Tax Burden Percent	100.09%	99.06%	-9,200.00%	104.71%	-30.83%	90.96%	100.66%	100.78%	100.70%	100.53%
Interest Burden Percent	335.04%	124.18%	-0.04%	95.12%	100.00%	107.09%	149.88%	119.58%	103.91%	118.99%
Effective Tax Rate	0.00%	0.94%	9,300.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-53.10%	23.93%	1,033.24%	-41.57%	-13.68%	-18.54%	-5.19%	-12.87%	-20.13%	-19.32%
ROIC Less NNEP Spread (ROIC-NNEP)	43.34%	23.57%	1,228.67%	-38.70%	-44.13%	-1.94%	9.26%	24.62%	71.87%	16.17%
Return on Net Nonoperating Assets (RNNOA)	-30.51%	-19.67%	-1,033.32%	33.27%	17.32%	0.59%	-2.72%	-4.89%	-7.02%	-4.50%
Return on Equity (ROE)	-83.61%	4.26%	-0.07%	-8.30%	3.64%	-17.95%	-7.91%	-17.76%	-27.16%	-23.83%
Cash Return on Invested Capital (CROIC)	-54.74%	-20.21%	1,044.29%	-66.28%	-194.56%	-8.46%	-5.37%	-14.64%	-18.26%	-19.33%
Operating Return on Assets (OROA)	-16.02%	2.93%	-1.52%	-6.98%	-9.76%	-13.55%	-3.20%	-8.02%	-13.25%	-12.78%
Return on Assets (ROA)	-53.72%	3.60%	-0.06%	-6.95%	3.01%	-13.20%	-4.83%	-9.67%	-13.86%	-15.29%
Return on Common Equity (ROCE)	51.18%	4.26%	-0.07%	-8.30%	3.64%	-17.95%	-7.91%	-17.76%	-27.16%	-23.83%
Return on Equity Simple (ROE_SIMPLE)	-40.26%	3.86%	-0.07%	-7.45%	2.29%	-18.03%	-8.45%	-18.72%	-29.16%	-19.09%
Net Operating Profit after Tax (NOPAT)	-7.21	4.20	210	-9.10	-35	-86	-23	-58	-90	-86
NOPAT Margin	-10.05%	3.67%	131.77%	-5.02%	-14.86%	-38.45%	-7.83%	-20.37%	-28.63%	-22.34%
Net Nonoperating Expense Percent (NNEP)	-96.44%	0.36%	-195.43%	-2.87%	30.45%	-16.61%	-14.45%	-37.49%	-92.01%	-35.49%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-7.10%	-12.10%	-11.17%
Cost of Revenue to Revenue	18.11%	14.14%	13.22%	13.83%	16.28%	40.77%	22.66%	24.39%	24.01%	24.52%
SG&A Expenses to Revenue	61.31%	56.61%	60.44%	0.00%	74.53%	76.19%	60.97%	68.20%	71.20%	68.10%
R&D to Revenue	34.93%	25.55%	27.77%	27.40%	30.40%	37.96%	37.75%	47.12%	45.68%	39.29%
Operating Expenses to Revenue	96.25%	82.15%	88.21%	93.34%	104.94%	114.15%	88.52%	104.71%	116.88%	107.39%
Earnings before Interest and Taxes (EBIT)	-11	3.68	-2.28	-13	-50	-124	-33	-82	-129	-122
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-7.10	8.61	3.22	-7.03	-41	-58	3.95	-45	-95	-82
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.33	9.81	6.42	11.64	2.99	5.07	3.55	3.93	8.40	10.78
Price to Tangible Book Value (P/TBV)	9.33	10.39	6.56	11.64	8.96	13.89	11.07	13.36	34.43	18.90
Price to Revenue (P/Rev)	11.05	10.06	5.57	11.16	8.49	15.04	7.09	7.37	12.33	21.56
Price to Earnings (P/E)	0.00	254.48	0.00	0.00	130.41	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.39%	0.00%	0.00%	0.77%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	51.97	49.22	40.00	76.56	3.75	7.15	4.39	4.46	8.72	17.93
Enterprise Value to Revenue (EV/Rev)	9.92	9.22	4.82	10.39	7.75	14.09	6.63	7.11	12.29	20.73
Enterprise Value to EBITDA (EV/EBITDA)	0.00	122.55	238.31	0.00	0.00	0.00	493.61	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	286.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	251.10	3.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	85.70	29.42	99.83	0.00	0.00	78.91	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	3.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.10	0.00	0.00	0.00	0.00	0.28	0.48	0.53	0.61	0.00
Long-Term Debt to Equity	0.01	0.00	0.00	0.00	0.00	0.28	0.48	0.53	0.61	0.00
Financial Leverage	-0.70	-0.83	-0.84	-0.86	-0.39	-0.30	-0.29	-0.20	-0.10	-0.28
Leverage Ratio	1.56	1.18	1.18	1.19	1.21	1.36	1.64	1.84	1.96	1.56
Compound Leverage Factor	5.22	1.47	0.00	1.14	1.21	1.46	2.46	2.20	2.04	1.85
Debt to Total Capital	9.24%	0.00%	0.00%	0.00%	0.00%	22.11%	32.29%	34.68%	37.98%	0.00%
Short-Term Debt to Total Capital	8.51%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.73%	0.00%	0.00%	0.00%	0.00%	22.11%	32.29%	34.68%	37.98%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	90.76%	100.00%	100.00%	100.00%	100.00%	77.89%	67.71%	65.32%	62.02%	100.00%
Debt to EBITDA	-1.37	0.00	0.00	0.00	0.00	-3.28	70.89	-6.25	-2.97	0.00
Net Debt to EBITDA	11.49	0.00	0.00	0.00	0.00	3.72	-33.93	1.58	0.13	0.00
Long-Term Debt to EBITDA	-0.11	0.00	0.00	0.00	0.00	-3.28	70.89	-6.25	-2.97	0.00
Debt to NOPAT	-1.35	0.00	0.00	0.00	0.00	-2.19	-12.17	-4.88	-3.14	0.00
Net Debt to NOPAT	11.31	0.00	0.00	0.00	0.00	2.49	5.82	1.24	0.14	0.00
Long-Term Debt to NOPAT	-0.11	0.00	0.00	0.00	0.00	-2.19	-12.17	-4.88	-3.14	0.00
Altman Z-Score	20.94	40.24	19.43	36.80	8.38	5.89	2.88	2.45	4.26	23.24
Noncontrolling Interest Sharing Ratio	161.21%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.11	7.09	5.58	5.81	4.56	9.45	7.67	6.13	5.34	5.99
Quick Ratio	4.85	6.50	5.06	5.24	3.68	8.86	7.06	5.37	4.53	5.05
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-7.43	-3.55	212	-15	-501	-39	-24	-66	-82	-86
Operating Cash Flow to CapEx	-249.49%	196.07%	413.42%	182.88%	-7.81%	-331.48%	51.71%	-109.86%	-285.25%	-979.21%
Free Cash Flow to Firm to Interest Expense	-5.91	0.00	0.00	-8.97	-171.84	-3.54	-1.35	-3.54	-5.76	-2.50
Operating Cash Flow to Interest Expense	-1.74	0.00	0.00	11.66	-0.13	-2.06	1.40	-1.79	-4.07	-1.79
Operating Cash Flow Less CapEx to Interest Expense	-2.44	0.00	0.00	5.28	-1.75	-2.69	-1.30	-3.42	-5.50	-1.97
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.01	0.91	1.06	0.97	0.46	0.25	0.29	0.28	0.32	0.40
Accounts Receivable Turnover	11.08	10.47	10.29	10.26	8.30	6.04	8.46	8.14	8.29	7.62
Inventory Turnover	4.09	2.96	2.33	2.05	1.38	3.14	3.43	2.27	1.89	1.89
Fixed Asset Turnover	34.94	23.47	16.43	11.72	11.50	9.77	6.32	3.46	3.19	3.81
Accounts Payable Turnover	3.75	4.91	4.57	4.00	6.40	18.07	11.39	6.35	5.43	7.11
Days Sales Outstanding (DSO)	32.95	34.86	35.48	35.57	43.96	60.42	43.14	44.85	44.03	47.87
Days Inventory Outstanding (DIO)	89.30	123.43	156.63	178.34	264.19	116.18	106.33	161.00	192.77	193.44
Days Payable Outstanding (DPO)	97.29	74.38	79.86	91.20	57.07	20.20	32.06	57.51	67.24	51.37
Cash Conversion Cycle (CCC)	24.96	83.92	112.25	122.72	251.08	156.40	117.41	148.34	169.56	189.95
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	14	21	19	25	490	443	444	452	443	443
Invested Capital Turnover	5.28	6.52	7.84	8.28	0.92	0.48	0.66	0.63	0.70	0.87
Increase / (Decrease) in Invested Capital	0.22	7.75	-2.24	5.41	465	-47	0.78	7.92	-8.38	0.03
Enterprise Value (EV)	711	1,055	768	1,883	1,837	3,169	1,950	2,012	3,866	7,948
Market Capitalization	793	1,151	887	2,024	2,011	3,384	2,084	2,084	3,879	8,267
Book Value per Share	$2.97	$3.50	$4.00	$4.83	$18.23	$14.84	$12.52	$11.11	$9.46	$13.91
Tangible Book Value per Share	$2.65	$3.30	$3.91	$4.83	$6.08	$5.42	$4.01	$3.27	$2.31	$7.93
Total Capital	105	117	138	174	673	857	867	811	745	767
Total Debt	9.70	0.00	0.00	0.00	0.00	189	280	281	283	0.00
Total Long-Term Debt	0.77	0.00	0.00	0.00	0.00	189	280	281	283	0.00
Net Debt	-82	-96	-119	-140	-174	-215	-134	-71	-13	-319
Capital Expenditures (CapEx)	0.88	6.28	6.31	10	4.72	6.94	48	30	20	6.26
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1.51	7.24	3.66	5.71	31	15	8.72	19	26	56
Debt-free Net Working Capital (DFNWC)	93	103	123	146	205	420	423	372	321	375
Net Working Capital (NWC)	84	103	123	146	205	420	423	372	321	375
Net Nonoperating Expense (NNE)	31	-0.32	210	3.85	-51	34	27	42	45	61
Net Nonoperating Obligations (NNO)	-82	-96	-119	-149	-183	-225	-143	-78	-19	-324
Total Depreciation and Amortization (D&A)	4.33	4.93	5.50	5.97	9.53	66	37	37	33	41
Debt-free, Cash-free Net Working Capital to Revenue	2.10%	6.33%	2.30%	3.15%	13.16%	6.83%	2.96%	6.65%	8.27%	14.54%
Debt-free Net Working Capital to Revenue	129.30%	90.11%	77.03%	80.65%	86.58%	186.59%	143.79%	131.34%	102.14%	97.70%
Net Working Capital to Revenue	116.85%	90.11%	77.03%	80.65%	86.58%	186.59%	143.79%	131.34%	102.14%	97.70%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($2.13)	$0.14	$0.00	($0.37)	$0.41	($2.70)	$0.00	$0.00	($2.78)	($2.77)
Adjusted Weighted Average Basic Shares Outstanding	32.34M	32.93M	34.38M	35.32M	37.36M	44.50M	0.00	0.00	48.43M	52.76M
Adjusted Diluted Earnings per Share	($2.13)	$0.12	$0.00	($0.37)	$0.37	($2.70)	$0.00	$0.00	($2.78)	($2.77)
Adjusted Weighted Average Diluted Shares Outstanding	32.34M	36.46M	34.38M	35.32M	41.15M	44.50M	0.00	0.00	48.43M	52.76M
Adjusted Basic & Diluted Earnings per Share	($2.13)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	17.47M	34.23M	34.74M	36.16M	43.74M	45.79M	0.00	0.00	49.47M	56.57M
Normalized Net Operating Profit after Tax (NOPAT)	-7.21	4.20	-1.60	-9.10	-35	-86	-44	-79	-90	-86
Normalized NOPAT Margin	-10.05%	3.67%	-1.00%	-5.02%	-14.86%	-38.45%	-14.97%	-27.79%	-28.63%	-22.34%
Pre Tax Income Margin	-53.40%	3.99%	0.00%	-6.82%	-21.11%	-58.82%	-16.76%	-34.80%	-42.49%	-37.97%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-9.09	0.00	0.00	-8.04	-17.18	-11.09	-1.86	-4.45	-9.07	-3.56
NOPAT to Interest Expense	-5.73	0.00	0.00	-5.63	-12.09	-7.76	-1.30	-3.12	-6.35	-2.49
EBIT Less CapEx to Interest Expense	-9.79	0.00	0.00	-14.41	-18.80	-11.71	-4.56	-6.08	-10.50	-3.75
NOPAT Less CapEx to Interest Expense	-6.43	0.00	0.00	-12.00	-13.71	-8.39	-4.00	-4.74	-7.78	-2.68
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Glaukos' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-4.61%	-2.75%	9.19%	10.61%	9.51%	15.64%	15.86%	19.02%	23.86%	28.09%	24.58%
EBITDA Growth	-170.38%	-151.41%	-233.39%	36.70%	-63.61%	-41.83%	-30.94%	-4.92%	34.49%	59.19%	63.76%
EBIT Growth	-326.20%	-88.79%	-473.56%	27.55%	-37.52%	-14.49%	-21.52%	-2.60%	25.07%	25.78%	50.78%
NOPAT Growth	-241.67%	-88.79%	-350.16%	20.91%	-29.61%	-14.49%	-18.41%	-3.09%	11.96%	25.78%	47.07%
Net Income Growth	-542.63%	-43.84%	-743.97%	27.94%	-10.40%	-16.91%	-17.94%	-54.04%	29.68%	8.70%	55.57%
EPS Growth	-546.15%	-43.48%	-754.55%	29.17%	-8.62%	-13.64%	-13.89%	-47.06%	38.10%	25.33%	60.98%
Operating Cash Flow Growth	-249.04%	11.07%	-414.75%	33.14%	69.19%	-157.86%	-10.10%	-125.08%	-17.36%	104.75%	45.32%
Free Cash Flow Firm Growth	-216.64%	-137.34%	-536.97%	-17.62%	-8.62%	40.84%	51.79%	60.74%	7.88%	-7.73%	-16.44%
Invested Capital Growth	1.54%	1.79%	2.72%	4.15%	0.94%	-1.86%	-2.21%	-1.25%	1.03%	0.01%	1.19%
Revenue Q/Q Growth	-1.95%	-0.06%	3.75%	8.80%	-2.92%	5.53%	3.95%	11.76%	1.02%	9.13%	1.10%
EBITDA Q/Q Growth	62.71%	-62.24%	-17.82%	8.05%	3.63%	-40.64%	-9.03%	26.32%	39.82%	12.38%	6.72%
EBIT Q/Q Growth	49.28%	-56.10%	2.20%	6.43%	3.73%	-29.96%	-3.81%	21.00%	29.70%	-28.73%	31.16%
NOPAT Q/Q Growth	41.21%	-56.10%	2.20%	11.88%	3.66%	-37.89%	-1.15%	23.27%	17.73%	-16.24%	27.87%
Net Income Q/Q Growth	39.44%	-14.08%	-10.06%	5.24%	7.22%	-20.81%	-11.04%	-23.77%	57.64%	-56.85%	45.96%
EPS Q/Q Growth	39.58%	-13.79%	-9.09%	5.56%	7.35%	-19.05%	-9.33%	-21.95%	61.00%	-43.59%	42.86%
Operating Cash Flow Q/Q Growth	-117.23%	84.40%	-643.81%	73.47%	-0.09%	-30.57%	-217.58%	45.77%	47.81%	105.29%	-3,753.06%
Free Cash Flow Firm Q/Q Growth	33.36%	-43.77%	-12.25%	-9.37%	38.46%	21.70%	8.51%	10.94%	-44.39%	8.43%	1.11%
Invested Capital Q/Q Growth	1.42%	0.55%	3.05%	-0.90%	-1.70%	-2.23%	2.68%	0.07%	0.57%	-3.23%	3.89%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	76.34%	75.82%	75.55%	75.00%	76.28%	77.06%	76.34%	76.43%	76.64%	72.86%	77.20%
EBITDA Margin	-18.54%	-30.10%	-33.02%	-27.91%	-27.70%	-36.92%	-37.31%	-24.60%	-14.65%	-11.76%	-10.85%
Operating Margin	-30.32%	-47.36%	-44.65%	-36.16%	-35.89%	-46.89%	-45.63%	-31.32%	-25.51%	-27.17%	-19.39%
EBIT Margin	-30.32%	-47.36%	-44.65%	-38.40%	-38.08%	-46.89%	-46.83%	-33.10%	-23.04%	-27.17%	-18.50%
Profit (Net Income) Margin	-38.69%	-44.17%	-46.86%	-40.81%	-39.01%	-44.65%	-47.70%	-52.82%	-22.15%	-31.83%	-17.01%
Tax Burden Percent	100.90%	100.96%	101.17%	101.34%	100.12%	100.17%	100.93%	100.66%	100.83%	99.66%	101.83%
Interest Burden Percent	126.46%	92.38%	103.73%	104.88%	102.32%	95.07%	100.92%	158.53%	95.34%	117.54%	90.31%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-13.57%	-20.95%	-19.67%	-16.62%	-16.90%	-23.09%	-22.65%	-16.35%	-14.12%	-16.45%	-11.99%
ROIC Less NNEP Spread (ROIC-NNEP)	-3.92%	-13.87%	-7.38%	0.31%	0.62%	-2.97%	47.07%	8.57%	-10.59%	-8.56%	-9.53%
Return on Net Nonoperating Assets (RNNOA)	0.88%	2.75%	1.25%	-0.04%	-0.08%	0.29%	-1.90%	-1.76%	2.17%	2.38%	2.35%
Return on Equity (ROE)	-12.69%	-18.19%	-18.42%	-16.66%	-16.98%	-22.80%	-24.55%	-18.11%	-11.95%	-14.07%	-9.64%
Cash Return on Invested Capital (CROIC)	-11.96%	-14.64%	-21.75%	-22.24%	-20.14%	-18.26%	-18.26%	-19.46%	-21.35%	-19.33%	-17.08%
Operating Return on Assets (OROA)	-8.34%	-13.06%	-12.75%	-11.47%	-11.81%	-15.19%	-16.04%	-12.06%	-8.85%	-10.88%	-7.88%
Return on Assets (ROA)	-10.64%	-12.18%	-13.38%	-12.19%	-12.10%	-14.47%	-16.34%	-19.24%	-8.51%	-12.75%	-7.25%
Return on Common Equity (ROCE)	-12.69%	-18.19%	-18.42%	-16.66%	-16.98%	-22.80%	-24.55%	-18.11%	-11.95%	-14.07%	-9.64%
Return on Equity Simple (ROE_SIMPLE)	-16.34%	0.00%	-27.37%	-25.87%	-27.08%	0.00%	-31.25%	-23.84%	-22.37%	0.00%	-16.19%
Net Operating Profit after Tax (NOPAT)	-15	-24	-23	-20	-20	-27	-27	-21	-17	-20	-14
NOPAT Margin	-21.23%	-33.15%	-31.25%	-25.31%	-25.12%	-32.82%	-31.94%	-21.93%	-17.86%	-19.02%	-13.57%
Net Nonoperating Expense Percent (NNEP)	-9.65%	-7.07%	-12.30%	-16.93%	-17.52%	-20.11%	-69.72%	-24.92%	-3.53%	-7.90%	-2.46%
Return On Investment Capital (ROIC_SIMPLE)	-	-2.91%	-	-	-	-3.63%	-	-	-	-2.62%	-1.89%
Cost of Revenue to Revenue	23.66%	24.18%	24.45%	25.00%	23.72%	22.94%	23.66%	23.57%	23.36%	27.14%	22.80%
SG&A Expenses to Revenue	66.16%	72.90%	72.60%	66.09%	69.50%	76.53%	72.38%	69.17%	66.20%	65.41%	66.26%
R&D to Revenue	40.51%	50.28%	47.59%	45.07%	42.67%	47.43%	49.58%	38.59%	35.94%	34.62%	30.33%
Operating Expenses to Revenue	106.66%	123.18%	120.19%	111.16%	112.17%	123.96%	121.97%	107.76%	102.15%	100.03%	96.59%
Earnings before Interest and Taxes (EBIT)	-22	-34	-33	-31	-30	-39	-40	-32	-22	-29	-20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-13	-21	-24	-22	-22	-30	-32	-24	-14	-12	-12
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.62	3.93	4.72	7.02	7.66	8.40	10.21	8.96	10.71	10.78	7.29
Price to Tangible Book Value (P/TBV)	15.05	13.36	17.04	26.97	29.92	34.43	44.81	18.44	21.50	18.90	12.65
Price to Revenue (P/Rev)	8.90	7.37	8.30	11.57	12.06	12.33	14.10	17.44	19.87	21.56	13.76
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	5.46	4.46	5.08	7.40	8.03	8.72	10.13	12.64	15.18	17.93	11.44
Enterprise Value to Revenue (EV/Rev)	8.61	7.11	8.17	11.49	12.00	12.29	14.13	16.84	19.30	20.73	13.02
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.51	0.53	0.55	0.58	0.59	0.61	0.63	0.09	0.08	0.00	0.00
Long-Term Debt to Equity	0.51	0.53	0.55	0.58	0.59	0.61	0.63	0.09	0.08	0.00	0.00
Financial Leverage	-0.22	-0.20	-0.17	-0.14	-0.12	-0.10	-0.04	-0.21	-0.20	-0.28	-0.25
Leverage Ratio	1.80	1.84	1.83	1.89	1.91	1.96	1.99	1.63	1.64	1.56	1.56
Compound Leverage Factor	2.28	1.70	1.90	1.98	1.95	1.86	2.01	2.58	1.56	1.83	1.41
Debt to Total Capital	33.88%	34.68%	35.65%	36.59%	37.16%	37.98%	38.58%	7.85%	7.83%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	33.88%	34.68%	35.65%	36.59%	37.16%	37.98%	38.58%	7.85%	7.83%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	66.12%	65.32%	64.35%	63.41%	62.84%	62.02%	61.42%	92.15%	92.17%	100.00%	100.00%
Debt to EBITDA	-8.76	-6.25	-3.20	-3.57	-3.30	-2.97	-2.90	-0.57	-0.60	0.00	0.00
Net Debt to EBITDA	2.51	1.58	0.41	0.28	0.22	0.13	-0.11	2.08	2.16	0.00	0.00
Long-Term Debt to EBITDA	-8.76	-6.25	-3.20	-3.57	-3.30	-2.97	-2.90	-0.57	-0.60	0.00	0.00
Debt to NOPAT	-6.04	-4.88	-3.22	-3.43	-3.26	-3.14	-3.00	-0.60	-0.61	0.00	0.00
Net Debt to NOPAT	1.73	1.24	0.41	0.26	0.21	0.14	-0.11	2.16	2.22	0.00	0.00
Long-Term Debt to NOPAT	-6.04	-4.88	-3.22	-3.43	-3.26	-3.14	-3.00	-0.60	-0.61	0.00	0.00
Altman Z-Score	3.38	2.61	3.00	4.25	4.47	4.58	5.38	13.67	16.30	23.56	16.23
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	7.40	6.13	6.67	6.28	5.95	5.34	5.38	5.48	5.54	5.99	6.49
Quick Ratio	6.54	5.37	5.70	5.37	5.07	4.53	4.42	4.46	4.45	5.05	5.40
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-22	-32	-35	-39	-24	-19	-17	-15	-22	-20	-20
Operating Cash Flow to CapEx	-439.06%	-50.65%	-445.34%	-141.54%	-243.10%	-253.09%	-3,498.97%	-854.77%	-661.10%	29.26%	-955.68%
Free Cash Flow to Firm to Interest Expense	-6.30	-3.86	-10.39	-11.39	-7.01	-4.68	-4.95	-0.71	-13.20	-2.56	-17.09
Operating Cash Flow to Interest Expense	-7.62	-0.51	-9.03	-2.40	-2.40	-2.68	-9.82	-0.86	-5.76	0.06	-15.93
Operating Cash Flow Less CapEx to Interest Expense	-9.35	-1.50	-11.05	-4.10	-3.39	-3.73	-10.10	-0.96	-6.64	-0.16	-17.59
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.27	0.28	0.29	0.30	0.31	0.32	0.34	0.36	0.38	0.40	0.43
Accounts Receivable Turnover	8.14	8.14	7.96	7.88	8.19	8.29	7.74	7.55	7.53	7.62	6.85
Inventory Turnover	2.55	2.27	2.15	2.15	2.00	1.89	1.72	1.67	1.69	1.89	1.79
Fixed Asset Turnover	3.85	3.46	3.34	3.23	3.19	3.19	3.26	3.37	3.57	3.81	4.07
Accounts Payable Turnover	6.89	6.35	6.99	4.84	6.76	5.43	6.28	7.97	7.83	7.11	6.86
Days Sales Outstanding (DSO)	44.85	44.85	45.87	46.29	44.54	44.03	47.18	48.32	48.49	47.87	53.27
Days Inventory Outstanding (DIO)	143.35	161.00	169.92	169.95	182.64	192.77	212.72	218.26	215.83	193.44	204.01
Days Payable Outstanding (DPO)	52.99	57.51	52.22	75.41	54.02	67.24	58.16	45.79	46.59	51.37	53.17
Cash Conversion Cycle (CCC)	135.21	148.34	163.57	140.83	173.16	169.56	201.75	220.79	217.73	189.95	204.11
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	449	452	465	461	453	443	455	455	458	443	461
Invested Capital Turnover	0.64	0.63	0.63	0.66	0.67	0.70	0.71	0.75	0.79	0.87	0.88
Increase / (Decrease) in Invested Capital	6.81	7.92	12	18	4.22	-8.38	-10	-5.78	4.69	0.03	5.40
Enterprise Value (EV)	2,453	2,012	2,363	3,411	3,642	3,866	4,612	5,756	6,953	7,948	5,269
Market Capitalization	2,534	2,084	2,399	3,433	3,661	3,879	4,601	5,961	7,159	8,267	5,567
Book Value per Share	$11.53	$11.11	$10.62	$10.14	$9.82	$9.46	$9.09	$13.21	$12.17	$13.91	$13.51
Tangible Book Value per Share	$3.54	$3.27	$2.94	$2.64	$2.51	$2.31	$2.07	$6.42	$6.06	$7.93	$7.78
Total Capital	830	811	790	771	760	745	734	722	725	767	764
Total Debt	281	281	282	282	282	283	283	57	57	0.00	0.00
Total Long-Term Debt	281	281	282	282	282	283	283	57	57	0.00	0.00
Net Debt	-81	-71	-36	-22	-18	-13	10	-205	-206	-319	-299
Capital Expenditures (CapEx)	6.04	8.17	6.91	5.77	3.36	4.21	0.97	2.15	1.45	1.73	1.94
Debt-free, Cash-free Net Working Capital (DFCFNWC)	27	19	36	34	32	26	44	52	63	56	77
Debt-free Net Working Capital (DFNWC)	388	372	353	337	332	321	316	314	326	375	376
Net Working Capital (NWC)	388	372	353	337	332	321	316	314	326	375	376
Net Nonoperating Expense (NNE)	12	7.85	12	12	11	9.74	13	30	4.15	14	3.67
Net Nonoperating Obligations (NNO)	-99	-78	-43	-28	-24	-19	4.40	-210	-210	-324	-303
Total Depreciation and Amortization (D&A)	8.40	12	8.59	8.44	8.10	8.21	8.15	8.14	8.10	16	8.16
Debt-free, Cash-free Net Working Capital to Revenue	9.34%	6.65%	12.36%	11.31%	10.38%	8.27%	13.33%	15.23%	17.52%	14.54%	19.11%
Debt-free Net Working Capital to Revenue	136.28%	131.34%	122.28%	113.67%	109.49%	102.14%	96.92%	91.80%	90.36%	97.70%	92.95%
Net Working Capital to Revenue	136.28%	131.34%	122.28%	113.67%	109.49%	102.14%	96.92%	91.80%	90.36%	97.70%	92.95%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.58)	($0.66)	($0.72)	($0.68)	($0.63)	($0.75)	($0.82)	($1.00)	($0.39)	($0.56)	($0.32)
Adjusted Weighted Average Basic Shares Outstanding	47.61M	47.44M	47.88M	48.28M	48.68M	48.43M	49.58M	50.72M	55.04M	52.76M	56.64M
Adjusted Diluted Earnings per Share	($0.58)	($0.66)	($0.72)	($0.68)	($0.63)	($0.75)	($0.82)	($1.00)	($0.39)	($0.56)	($0.32)
Adjusted Weighted Average Diluted Shares Outstanding	47.61M	47.44M	47.88M	48.28M	48.68M	48.43M	49.58M	50.72M	55.04M	52.76M	56.64M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	47.70M	47.88M	48.21M	48.65M	48.80M	49.47M	50.37M	54.95M	55.14M	56.57M	57.14M
Normalized Net Operating Profit after Tax (NOPAT)	-15	-24	-23	-20	-20	-27	-27	-21	-17	-20	-14
Normalized NOPAT Margin	-21.23%	-33.15%	-31.25%	-25.31%	-25.12%	-32.82%	-31.94%	-21.93%	-17.86%	-19.02%	-13.57%
Pre Tax Income Margin	-38.35%	-43.75%	-46.31%	-40.27%	-38.96%	-44.58%	-47.26%	-52.48%	-21.96%	-31.94%	-16.71%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-6.21	-4.12	-9.68	-9.08	-8.75	-9.69	-11.62	-1.48	-13.39	-3.65	-16.97
NOPAT to Interest Expense	-4.35	-2.89	-6.78	-5.99	-5.77	-6.78	-7.93	-0.98	-10.38	-2.55	-12.45
EBIT Less CapEx to Interest Expense	-7.94	-5.12	-11.71	-10.78	-9.73	-10.75	-11.90	-1.58	-14.26	-3.87	-18.63
NOPAT Less CapEx to Interest Expense	-6.08	-3.89	-8.80	-7.68	-6.76	-7.84	-8.21	-1.08	-11.25	-2.77	-14.11
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Glaukos' Financials

When does Glaukos's financial year end?

According to the most recent income statement we have on file, Glaukos' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Glaukos' net income changed over the last 9 years?

Glaukos' net income appears to be on an upward trend, with a most recent value of -$146.37 million in 2024, rising from -$38.32 million in 2015. The previous period was -$134.66 million in 2023. Check out Glaukos' forecast to explore projected trends and price targets.

What is Glaukos's operating income?

Glaukos's total operating income in 2024 was -$122.37 million, based on the following breakdown:

Total Gross Profit: $289.45 million
Total Operating Expenses: $411.82 million

How has Glaukos revenue changed over the last 9 years?

Over the last 9 years, Glaukos' total revenue changed from $71.70 million in 2015 to $383.48 million in 2024, a change of 434.8%.

How much debt does Glaukos have?

Glaukos' total liabilities were at $207.83 million at the end of 2024, a 56.6% decrease from 2023, and a 868.0% increase since 2015.

How much cash does Glaukos have?

In the past 9 years, Glaukos' cash and equivalents has ranged from $6.49 million in 2016 to $169.63 million in 2024, and is currently $169.63 million as of their latest financial filing in 2024.

How has Glaukos' book value per share changed over the last 9 years?

Over the last 9 years, Glaukos' book value per share changed from 2.97 in 2015 to 13.91 in 2024, a change of 369.1%.

Related Companies

This page (NYSE:GKOS) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Glaukos (GKOS) Financials

Frequently Asked Questions About Glaukos' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Glaukos (GKOS) Financials

Annual Income Statements for Glaukos

Quarterly Income Statements for Glaukos

Annual Cash Flow Statements for Glaukos

Quarterly Cash Flow Statements for Glaukos

Annual Balance Sheets for Glaukos

Quarterly Balance Sheets for Glaukos

Annual Metrics and Ratios for Glaukos

Quarterly Metrics and Ratios for Glaukos

Frequently Asked Questions About Glaukos' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools